Fundraising Fox

Arcus Biosciences

9 known investors

arcusbio.com ↗

Arcus Biosciences develops combination cancer therapies, producing small molecules and antibodies designed to be combined and advanced from Phase 1 studies through commercialization. The company focuses on oncology treatments guided by specific biologic mechanisms of cancer.

Biotech

Founders & leadership

JJ
Juan JaeninPresident, Co-Founder, Board of Directors

Investors · 9

Aisling CapitalNew York
Decheng CapitalMenlo Park
Droia VenturesLeuven · $540K
EcoR1 CapitalSan Francisco
Foresite CapitalLarkspur
SLVC
Sofinnova VenturesMenlo Park · $100K – $15M
Taiho Ventures, LLCMenlo Park
The Column GroupSan Francisco · $30M

In the news

Investigation launched into Arcus Biosciences o... | Pluangpluang.com · Aug 2026Kuehn Law Encourages Investors of Arcus Biosciences, Inc. to Contact Law Firmprnewswire.com · Aug 2026Arcus Biosciences earnings beat by $0.18, revenue topped estimates By Investing.cominvesting.com · Aug 2026H.C. Wainwright raises Arcus Biosciences stock price target to $45 By Investing.cominvesting.com · Jul 2026

Frequently asked questions

What does Arcus Biosciences do?
Arcus Biosciences develops combination cancer therapies, producing small molecules and antibodies designed to be combined and advanced from Phase 1 studies through commercialization. The company focuses on oncology treatments guided by specific biologic mechanisms of cancer.
Who founded Arcus Biosciences?
Arcus Biosciences was founded by Juan Jaen.
Who are Arcus Biosciences's investors?
Arcus Biosciences's investors include Aisling Capital, Decheng Capital, Droia Ventures, EcoR1 Capital, Foresite Capital, SLVC, Sofinnova Ventures, Taiho Ventures, LLC and 1 more.